A randomized controlled trial of acarbose in hepatic encephalopathy

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 2, 2005, Pages 184-191

  Gentile, Sandro ^a,b   Guarino, Giuseppina ^a   Romano, Marco ^a   Alagia, Ivo A ^a   Fierro, Maura ^a   Annunziata, Stefano ^a   Magliano, Paolo L ^a   Gravina, Antonietta G ^a   Torella, Roberto ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; AMMONIA; C PEPTIDE; HEMOGLOBIN; PLACEBO;

ABDOMINAL PRESSURE; ADULT; AGED; AMMONIA BLOOD LEVEL; ARTICLE; BLOATING; BODY WEIGHT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; FEMALE; FLATULENCE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCATION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTELLECT; INTESTINE MOTILITY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATION; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT;

ACARBOSE; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HUMANS; HYPOGLYCEMIC AGENTS; LIVER CIRRHOSIS; MALE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 13544253737     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00667-6     Document Type: Article

References (43)

1. R.F. Butterworth Pathogenesis and treatment of portal-systemic encephalopathy an update Dig Dis Sci 37 1992 321 327
2. P. Ferenci Pathophysiology of hepatic encephalopathy Hepatogastroenterology 38 1991 371 376
3. A.L. Mardini, H.K. Barlett, C.O. Record Blood and brain concentrations of mercaptans in hepatic and metanethiol induced coma Gut 25 1984 284 290
4. P. Ferenci, G. Grimm, S. Meryl Successful longterm treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil Gastroenterology 96 1989 240 243
5. H.O. Conn Theoretic therapy of hepatic encephalopathy H.O. Conn J. Bircher Hepatic encephalopathy management with lactulose and related carbohydrates 1988 Medi-Ed Press East Lansing, MI 83 94
6. C. Loguercio, S. Gentile, P. Spinelli Protein load induced ureogenesis and ammoniogenesis in patients with non-alcoholic liver cirrhosis P. Gentilini M.U. Dianzani Pathophysiology of the liver 1988 Elsevier Science Publisher BV Amsterdam 155 164
7. B.A. Hansen, H. Vilstrup Increased intestinal hydrolysis of urea in patients with alcoholic cirrhosis Scand J Gastroenterol 20 1985 346 350
8. D. Festi, G. Mazzella, P. Parini Treatment of hepatic encephalopathy with non-absorbable antibiotics Ital J Gastroenterol 24 Suppl 2 1992 14 16
9. A.E. Read, C.F. McCarthy, K.W. Heaton Lactobacillus acidophilus (empac) in the treatment of hepatic encephalopathy Br Med J 1 1966 1267 1270
10. B. Naunyn Der Diabetes mellitus E. Nothnagel Handbuch Spez Path Ther 1898 A. Holder Wien
11. J.W. Conn, L.H. Newburg, M.W. Johnston Study on the carbohydrate metabolism in chronic infectious hepatitis Arch Intern 62 1938 765 772
12. W. Creutzefeld, H. Frerichs, K. Sicklinger Liver diseases and diabetes mellitus H. Popper F. Schaffner Progress in liver diseases 1970 Grune & Stratton New York 371 407
13. G. Megayese, E. Samols, V. Marks Glucose tolerance and diabetes mellitus in chronic liver disease Lancet ii 1967 1051 1055
14. S. Gentile, C. Loguercio, R. Marmo Incidence of altered glucose tolerance in liver cirrhosis Diabetes Res Clin Pract 22 1993 37 44
15. A.S. Pedrites Liver disease and diabetes mellitus Diabetes Rev 2 1994 1 18
16. C. Del Vecchio Blanco, S. Gentile, R. Marmo Alteration of glucose metabolism in chronic liver disease Diabetes Res Clin Pract 8 1990 29 36
17. R. Carratù, P. Parisi, S. Frullone Glibenclamide associated reversible cholestasis Eur J Med 1 1992 441 443
18. S. Gentile, S. Turco, G. Guarino Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis Diabetes Obes Metab 3 2001 33 40
19. J.L. Chiasson, R. Josse, J.A. Hunt The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus a multicenter controlled trial Ann Intern Med 121 1994 928 935
20. S. Gentile, S. Turco, E. Rossi Non-insulin-dependent diabetes mellitus and liver cirrhosis F. Belfiore Molecular and cell biology of type 2 diabetes and its complications 1998 Karger Front Diabetes Volume 14. Basel 168 171
21. H.J. Ahr, M. Boberg, H.P. Krause Pharmacokinetics of acarbose. Part 1: Absorption, concentration in plasma, metabolism and excretion after single administration of 14C-acarbose to rats, dogs and man Arzneim Forsch Drug Res 10 1989 1254 1260
22. I. Hillebrand, K. Boehme, G. Frank The effect of the alpha-glucosidase inhibitor Bay G5421 (acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels dose-time-response relationship in man Res Exp Med 175 1979 87 94
23. J. Schrezenmeir W. Creutzfeld First International Symposium on Acarbose 1982 Excerpta Medica Amsterdam 225-231
24. J.G. Fitz Hepatic encephalopathy Volume 2 M. Feldman L.S. Friedman M.H. Sleisenger Gastrointestinal and liver disease 7th ed. 2002 Saunders Philadelphia 1543 1549
25. G.B. Bolli Hypoglycemia unawareness Diabetes Metab 23 Suppl 3 1997 29 35
26. Report of Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1997 1183 1197
27. R.P.H. Pugh, I.M. Murray-Layon, J.L. Dawson Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
28. D.A. Drossman, E. Corazziari, N.J. Talley Rome II. The functional gastrointestinal disorders Diagnosis, pathophysiology and treatment a multinational consensus 2nd ed. 2000 Degnos Associates McLean, VA
29. G. Smith-Laing, S. Sherlock, O.K. Faber Effects of spontaneous portal-systemic shunting on insulin metabolism Gastroenterology 76 1979 685 690
30. D.G. Johnston, K.G.M.M. Alberti, F. Wright C-peptide and insulin in liver disease Diabetes 20 1978 201 206
31. C. Loguercio, C. Del Vecchio Blanco, M. Coltorti Psychometric tests and "latent portal-systemic encephalopathy." Br J Clin Pract 38 1984 407 411
32. R.M. Reitan Validity of the trail making test as an indication of organic brain damage Percept Mot Skills 8 1958 271 276
33. M.L. Zeneroli, G. Cioni, P. Ventura Interindividual variability of the number connection test J Hepatol 15 1992 263 264
34. A.S. Basile, E.A. Jones, P. Skolnick The pathogenesis and treatment of hepatic encephalopathy evidence for the involvement of benzodiazepine receptor ligands Pharmacol Rev 43 1991 27 62
35. A. Basile, E.A. Jones Ammonia and GABA-ergic neurotransmission interrelated factors in the pathogenesis of hepatic encephalopathy Hepatology 25 1997 1303 1305
36. N. Hotta, H. Kakuta, N. Koh The effect of acarbose on blood glucose profiles of Type II diabetic patients receiving insulin therapy Diabet Med 10 1993 355 358
37. C. Piñol, E. Guardiola, J. Sorel A double blind, randomized, placebo controlled study to assess the maximum insulin dose reduction achieved with acarbose in the treatment of insulin-requiring Type 2 diabetic patients Diabetes Nutr Metab 11 1998 242 248
38. P. Hollander Safety profile of acarbose, an α-glucosidase inhibitor Drugs 44 1992 47 53
39. S. Fisher, M. Hanefeld, M. Spengler European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus efficacy and safety of low and high doses Acta Diabetol 35 1998 34 40
40. R.J. Andrade, M.I. Lucena, M. Rodriguez-Mendizabal Hepatic injury caused by acarbose (letter) Ann Intern Med 124 1996 931
41. M. Carrascosa, F. Pascual, S. Aresti Acarbose-induced acute severe hepatotoxicity (letter) Lancet 349 1997 698 699
42. W.M. Lee Drug-induced hepatotoxicity N Engl J Med 26 1995 1118 1127
43. S. Gentile, S. Turco, G. Guarino Aminotransferase activity and acarbose treatment in patients with type 2 diabetes Diabetes Care 22 1999 1217 1218